Insulet Investor Relations Material
Latest events
Q1 2025
Insulet
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Insulet Corporation
Access all reports
Insulet Corporation is a medical device company that develops and manufactures tubeless insulin pump systems for people with diabetes. Its flagship product is a wearable device that delivers continuous subcutaneous insulin infusion. The company markets its technology directly and through partnerships with healthcare providers. Insulet Corporation is headquartered in Acton, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Insulet Corporation
Q1 2025
Insulet Corporation
Q1 2025
Insulet Corporation
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
PODD
Country
🇺🇸 United States